SCHEMBL13023928

SCHEMBL13023928

Cc1ccc(N2c3ccccc3CCCc3c2oc2ccccc32)c(-c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.37
NPSR1 Q6W5P4 6/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
LMNA P02545 4/20 0.36
KDM4E B2RXH2 3/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
HTT P42858 2/20 0.35
PDE4B Q07343 1/20 0.34
PDE4D Q08499 1/20 0.34
NPY1R P25929 1/20 0.34
NPY2R P49146 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13023924 0.94 MAPT (0.37) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13022850 0.88 NPSR1 (0.41) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023862 0.88 ACHE (0.35) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023914 0.88 ALDH1A1 (0.39) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13022135 0.85 NPSR1 (0.36) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023922 0.83 KMT2A (0.43) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023911 0.82 NPSR1 (0.40) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023935 0.82 NPSR1 (0.40) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13022851 0.82 MAPT (0.38) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1
SCHEMBL13023397 0.82 LMNA (0.40) MAPTNPSR1ALDH1A1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-11 US disclosed
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286360-A1 POLYMER COMPOUND AND POLYMER LIGHT EMITTING DEVICE USING THE SAME IGF1R, SCO2, CRY1 MAPT 2367/4885NPSR1 2345/4885ALDH1A1 579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.